Skip to main content

Table 3 Summary of perioperative fluids administered in the included studies

From: Association between perioperative fluid administration and postoperative outcomes: a 20-year systematic review and a meta-analysis of randomized goal-directed trials in major visceral/noncardiac surgery

Study

Total intraoperative fluid administration

Total perioperative

Fluid administration (95% CI)

Colloids (ml) (95% CI/SD)

Crystalloids (ml) (95% CI/SD)

Intraoperative blood (ml)

GDT

Controls

GDT

Controls

GDT

Controls

GDT

Controls

Conway [41]

1960 (NA)

1325 (NA)

NA

NA

NA

NA

4522 (NA)

3770 (NA)

Wakeling [42]

2000 (NA)*

1500 (NA)

3000 (NA)

3000 (NA)

NA

NA

5000 (NA)

4500 (NA)

Pearse [30]

1907 (NA)*

930 (NA)

1204 (NA)

960 (NA)

125 (0–734)

0 (0–485)

2837 (NA)

2164

Lobo [26]

NA

NA

NA

NA

713 (458)

609 (244)

7447 (NA)

6877 (NA)

Donati [31]

1940 (673)

1805 (611)

NA

NA

260 (130)

271 (173)

4131 (NA)

4014 (NA)

Benes [25]

1425 (1000–1500)

1000 (540–1250)

2321 (1640–3002)

2459 (1529–3389)

0 (0–500)

270 (0–578)

5333 (NA)

4987 (NA)

Mayer [43]

1188 (638–1738)*

817 (350–1284)

2489 (1684–3294)

3153 (1889–4417)*

NA

NA

4528 (2211–6845)

4494 (2933–6055)

Brandstrup [32]

810 (NA)*

475 (NA)

483 (NA)

443 (NA)

78 (278)

77 (407)

6144 (NA)

5909 (NA)

Salzwedel [27]

773 (109–1437)

724 (4–1444)

2862 (1646–4078)

2680 (1526–3834)

145 (371)

224 (1036)

7053 (NA)

7597(NA)

McKenny [44]

1000 (1000–1500)*

500 (0–1000)

1000 (787–1750)

2000 (1725–2500)*

NA

NA

2620 (NA)

2881 (NA)

Scheeren [28]

1589 (1150–2028)

927 (631–1223)

NA

NA

319 (495)

685 (832)

4477 (3740–5214)

4528 (3693–5363)

Srinivasa [45]

591 (471)

297 (275)

NA

NA

NA

NA

5744 (NA)

4014 (NA)

Pearse [19]

1250 (1000–2000)

500 (0–1000)

1000 (459–2000)

2000 (1283–3000)

NA

NA

3256 (NA)

3100 (NA)

Phan [46]

500 (250–750)*

0 (0–300)

1500 (1000–2000)

1400 (1000–2000)

NA

NA

4470 (NA)

3916 (NA)

Ackland [47]

500 (0–1000)

625 (0–1438)

3000 (2000–4000)

3000 (2000–4000)

NA

NA

5000 (NA)

4748 (NA)

Correa-Gallego [48]

NA

NA

NA

NA

NA

NA

3800 (NA)

4500 (NA)

Weinberg [34]

200 (500–700)

200 (175–550)

1875 (1000–2000)

4000 (2313–4206)*

NA

NA

4516 (NA)

7034 (NA)

Gomez-Izquierdo [49]

500 (323–687)

2102 (1600–2528)*

900 (400–1400)*

0 (0–500)

NA

NA

1819 (NA)

2914 (NA)

Wu [50]

900 (400–1400)*

0 (0–500)

500 (323–687)

2102 (1600–2528)

NA

NA

1535 (1000–2272)

2370 (1779–3071)

Zhao [33]

775 (539–1011)*

487 (435–539)

471 (371–571)

459 (427–491)

885 (377)

443 (140)

1478 (1167–1790)

1183 (1120–1246)

Weinberg yyy[29]

200 (500–700)

200 (175–550)

1875 (1000–2000)

2000 (1125–2000)

356 (248–465)

465 (465–465)

4950 (NA)

4450 (NA)

  1. NA, data not available; GDT, patients’ subgroup receiving goal-directed therapy; ml, milliliters. Data are reported including 95% confidence interval (95%CI) or standard deviation (SD), as appropriate; when NA is present after a value, it implies a computation of available data reported in the paper. Perioperative fluid therapy reports the overall amount of fluid includes the fluid infused during the operation and within the first 24 h in the critically ill area. * = difference reported in the study as statistically significant among GDT/controls subgroups regarding intraoperative colloids or crystalloids administration